• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[临床试验中治疗转换分析不同方法的比较研究]

[A comparative study of different methods for treatment switching analysis in clinical trials].

作者信息

Liang Zhiyue, Xu Lishan, Li Keke, Yu Milai, An Shengli

机构信息

Department of Biostatistics, School of Public Health, Southern Medical University, Guangzhou 510515, China.

出版信息

Nan Fang Yi Ke Da Xue Xue Bao. 2025 May 20;45(5):1093-1102. doi: 10.12122/j.issn.1673-4254.2025.05.23.

DOI:10.12122/j.issn.1673-4254.2025.05.23
PMID:40415442
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12104727/
Abstract

OBJECTIVES

To compare the commonly used methods for analyzing treatment switching in clinical trials to facilitate selection of optimal methods in different scenarios.

METHODS

Based on the data characteristics of patient conversion in oncology clinical trials, we simulated the survival time of patients across different scenarios and compared the bias, mean square error and coverages of the treatment effects derived from different methods.

RESULTS

The sample size had an almost negligible impact on the outcomes of the various methods. Compared to conventional methods, more complex methods (RPSFTM, IPCW, TSE, and IPE) resulted in lower errors across different scenarios. The IPCW method could cause a significant increase in errors in cases where the probability of conversion was high. The TSE method had the lowest error and mean squared error when the risk was low and the probability of conversion was high. The IPE method had an obvious advantage in the scenario with a low probability of conversion, but it may slightly underestimate the treatment effect when the inflation factor was small.

CONCLUSIONS

The choice of a specific method for analyzing cohort transition should be made based on considerations of both the probability of conversion and inflation factor in different scenarios.

摘要

目的

比较临床试验中分析治疗转换的常用方法,以便在不同情况下选择最佳方法。

方法

基于肿瘤学临床试验中患者转换的数据特征,我们模拟了不同情况下患者的生存时间,并比较了不同方法得出的治疗效果的偏差、均方误差和覆盖率。

结果

样本量对各种方法的结果影响几乎可以忽略不计。与传统方法相比,更复杂的方法(RPSFTM、IPCW、TSE和IPE)在不同情况下导致的误差更低。在转换概率较高的情况下,IPCW方法可能会导致误差显著增加。当风险较低且转换概率较高时,TSE方法的误差和均方误差最低。IPE方法在转换概率较低的情况下具有明显优势,但当膨胀因子较小时,可能会略微低估治疗效果。

结论

应根据不同情况下的转换概率和膨胀因子来选择分析队列转换的具体方法。

相似文献

1
[A comparative study of different methods for treatment switching analysis in clinical trials].[临床试验中治疗转换分析不同方法的比较研究]
Nan Fang Yi Ke Da Xue Xue Bao. 2025 May 20;45(5):1093-1102. doi: 10.12122/j.issn.1673-4254.2025.05.23.
2
Improved two-stage estimation to adjust for treatment switching in randomised trials: g-estimation to address time-dependent confounding.改进的两阶段估计法以调整随机试验中的治疗转换:用于解决时间依存性混杂的g估计法。
Stat Methods Med Res. 2020 Oct;29(10):2900-2918. doi: 10.1177/0962280220912524. Epub 2020 Mar 30.
3
Two-stage estimation to adjust for treatment switching in randomised trials: a simulation study investigating the use of inverse probability weighting instead of re-censoring.两阶段估计调整随机试验中的治疗转换:一项使用逆概率加权而不是重新分类来调整的模拟研究。
BMC Med Res Methodol. 2019 Mar 29;19(1):69. doi: 10.1186/s12874-019-0709-9.
4
Adjusting for treatment switching in randomised controlled trials - A simulation study and a simplified two-stage method.随机对照试验中治疗转换的调整——一项模拟研究及一种简化的两阶段方法
Stat Methods Med Res. 2017 Apr;26(2):724-751. doi: 10.1177/0962280214557578. Epub 2014 Nov 21.
5
6
A cautionary tale: an evaluation of the performance of treatment switching adjustment methods in a real world case study.一个警示性的故事:在一个真实世界的案例研究中评估治疗转换调整方法的性能。
BMC Med Res Methodol. 2024 Jan 22;24(1):17. doi: 10.1186/s12874-024-02140-6.
7
Causal inference for long-term survival in randomised trials with treatment switching: Should re-censoring be applied when estimating counterfactual survival times?在存在治疗转换的随机试验中对长期生存的因果推断:在估计反事实生存时间时是否应该重新删失?
Stat Methods Med Res. 2019 Aug;28(8):2475-2493. doi: 10.1177/0962280218780856. Epub 2018 Jun 25.
8
The net benefit for time-to-event outcome in oncology clinical trials with treatment switching.肿瘤临床试验中因治疗转换而导致的时间事件结局的净获益。
Clin Trials. 2023 Dec;20(6):670-680. doi: 10.1177/17407745231186081. Epub 2023 Jul 16.
9
Assessing methods for dealing with treatment switching in clinical trials: A follow-up simulation study.评估临床试验中处理治疗转换的方法:一项后续模拟研究。
Stat Methods Med Res. 2018 Mar;27(3):765-784. doi: 10.1177/0962280216642264. Epub 2016 Apr 25.
10
Assessing the treatment effect in a randomized controlled trial with extensive non-adherence: the EVOLVE trial.在存在广泛不依从情况的随机对照试验中评估治疗效果:EVOLVE试验。
Pharm Stat. 2015 May-Jun;14(3):242-51. doi: 10.1002/pst.1680. Epub 2015 Apr 6.

本文引用的文献

1
[A simulation study for handling two-way treatment switching in rare event scenarios].[一种针对罕见事件场景中双向治疗转换处理的模拟研究]
Zhonghua Liu Xing Bing Xue Za Zhi. 2025 Feb 10;46(2):334-344. doi: 10.3760/cma.j.cn112338-20240522-00295.
2
New Methods for Two-Stage Treatment Switching Estimation.两阶段治疗转换估计的新方法。
Pharm Stat. 2025 Jan-Feb;24(1):e2462. doi: 10.1002/pst.2462.
3
Adjusting for switches to multiple treatments: Should switches be handled separately or combined?针对转向多种治疗方法的调整:转换情况应单独处理还是合并处理?
Stat Methods Med Res. 2025 Feb;34(2):322-335. doi: 10.1177/09622802241300049. Epub 2025 Jan 17.
4
Is inverse probability of censoring weighting a safer choice than per-protocol analysis in clinical trials?在临床试验中,删失加权的逆概率方法比符合方案分析更安全吗?
Stat Methods Med Res. 2025 Feb;34(2):286-306. doi: 10.1177/09622802241289559. Epub 2024 Dec 12.
5
Treatment-Switching Adjustment of Overall Survival in CheckMate 227 Part 1 Evaluating First-Line Nivolumab Plus Ipilimumab Versus Chemotherapy for Metastatic Nonsmall Cell Lung Cancer.CheckMate 227 第 1 部分中评估一线纳武利尤单抗联合伊匹单抗与化疗治疗转移性非小细胞肺癌的总生存治疗转换调整。
Clin Lung Cancer. 2024 Nov;25(7):e362-e368. doi: 10.1016/j.cllc.2024.06.005. Epub 2024 Jun 29.
6
A cautionary tale: an evaluation of the performance of treatment switching adjustment methods in a real world case study.一个警示性的故事:在一个真实世界的案例研究中评估治疗转换调整方法的性能。
BMC Med Res Methodol. 2024 Jan 22;24(1):17. doi: 10.1186/s12874-024-02140-6.
7
Intention-to-treat versus as-treated versus per-protocol approaches to analysis.意向治疗分析、按治疗分析和按方案分析。
Korean J Anesthesiol. 2023 Dec;76(6):531-539. doi: 10.4097/kja.23278. Epub 2023 Nov 14.
8
Power and sample sizes estimation in clinical trials with treatment switching in intention-to-treat analysis: a simulation study.意向治疗分析中治疗转换的临床试验中的效能和样本量估计:一项模拟研究。
BMC Med Res Methodol. 2023 Feb 23;23(1):49. doi: 10.1186/s12874-023-01864-1.
9
Improved two-stage estimation to adjust for treatment switching in randomised trials: g-estimation to address time-dependent confounding.改进的两阶段估计法以调整随机试验中的治疗转换:用于解决时间依存性混杂的g估计法。
Stat Methods Med Res. 2020 Oct;29(10):2900-2918. doi: 10.1177/0962280220912524. Epub 2020 Mar 30.
10
Adjusting for Treatment Switching in Oncology Trials: A Systematic Review and Recommendations for Reporting.调整肿瘤学试验中的治疗转换:系统评价和报告建议。
Value Health. 2020 Mar;23(3):388-396. doi: 10.1016/j.jval.2019.10.015. Epub 2020 Jan 23.